- Home
- CLH vs PEN Comparison
CLH vs PEN Comparison
Compare CLH & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLH
- PEN
- Stock Information
- Founded
- CLH 1980
- PEN 2004
- Country
- CLH United States
- PEN United States
- Employees
- CLH N/A
- PEN N/A
- Industry
- CLH Environmental Services
- PEN Medical/Dental Instruments
- Sector
- CLH Industrials
- PEN Health Care
- Exchange
- CLH Nasdaq
- PEN Nasdaq
- Market Cap
- CLH 12.5B
- PEN 10.1B
- IPO Year
- CLH 1987
- PEN 2015
- Fundamental
- Price
- CLH $233.32
- PEN $238.44
- Analyst Decision
- CLH Buy
- PEN Strong Buy
- Analyst Count
- CLH 8
- PEN 16
- Target Price
- CLH $249.25
- PEN $302.40
- AVG Volume (30 Days)
- CLH 351.6K
- PEN 412.9K
- Earning Date
- CLH 07-30-2025
- PEN 07-29-2025
- Dividend Yield
- CLH N/A
- PEN N/A
- EPS Growth
- CLH 4.50
- PEN N/A
- EPS
- CLH 7.22
- PEN 1.08
- Revenue
- CLH $5,945,207,000.00
- PEN $1,240,100,000.00
- Revenue This Year
- CLH $5.21
- PEN $14.60
- Revenue Next Year
- CLH $5.07
- PEN $14.24
- P/E Ratio
- CLH $32.24
- PEN $220.72
- Revenue Growth
- CLH 8.52
- PEN 13.17
- 52 Week Low
- CLH $178.29
- PEN $148.00
- 52 Week High
- CLH $267.11
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- CLH 59.30
- PEN 26.12
- Support Level
- CLH $228.75
- PEN $240.12
- Resistance Level
- CLH $235.84
- PEN $253.94
- Average True Range (ATR)
- CLH 4.01
- PEN 5.78
- MACD
- CLH -0.03
- PEN -0.66
- Stochastic Oscillator
- CLH 75.80
- PEN 10.05
About CLH Clean Harbors Inc.
Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.